Janney Montgomery Scott LLC Biocryst Pharmaceuticals Inc Transaction History
Janney Montgomery Scott LLC
- $38.3 Billion
- Q2 2025
A detailed history of Janney Montgomery Scott LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 38,700 shares of BCRX stock, worth $336,690. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,700
Previous 50,661
23.61%
Holding current value
$336,690
Previous $380,000
8.68%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding BCRX
# of Institutions
295Shares Held
181MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$174 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$77.7 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$75.7 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$68 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.62B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...